Clinical trial
Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
NCT02663609 is registered in ClinicalTrials.gov with Corcept Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
- Lead sponsor
- Corcept Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- December 1, 2017
- Enrollment
- 24 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cushing's syndrome